Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PDE5A | O76074 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2358653 | 0.77 | CHRNB2 (0.45) | MAPTRAB9ACHRNB2CHRNA4POLB | |
| SCHEMBL2358657 | 0.77 | CHRNB2 (0.45) | MAPTRAB9ACHRNB2CHRNA4POLB | |
| SCHEMBL2305824 | 0.72 | HSD11B1 (0.44) | MAPTRAB9ACHRNB2CHRNA4CHRNB4 | |
| SCHEMBL2299688 | 0.72 | HSD11B1 (0.44) | MAPTRAB9ACHRNB2CHRNA4CHRNB4 | |
| SCHEMBL15011765 | 0.72 | HSD11B1 (0.44) | MAPTRAB9ACHRNB2CHRNA4CHRNB4 | |
| SCHEMBL2302659 | 0.72 | HSD11B1 (0.44) | MAPTRAB9ACHRNB2CHRNA4CHRNB4 | |
| SCHEMBL23089380 | 0.71 | MAPT (0.59) | MAPTRAB9ACHRNB2CHRNA4POLB | |
| SCHEMBL31106300 | 0.68 | MAPT (0.54) | MAPTRAB9ACHRNB2CHRNA4POLB | |
| SCHEMBL2302595 | 0.68 | MAPT (0.54) | MAPTRAB9ACHRNB2CHRNA4POLB | |
| SCHEMBL2299587 | 0.67 | CHRNB2 (0.40) | MAPTRAB9ACHRNB2CHRNA4POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2536730-A1 | PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 | Novartis AG (CH) | 2012-12-26 | — | — | EP | disclosed |
| WO-2011101409-A1 | PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 | NOVARTIS AG (CH) | 2011-08-25 | — | — | WO | disclosed |